Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,900
Price
$74.34
Total Value
$141.25K
Shares Held After
19,689
% of Holdings
8.8%
Day One Biopharmaceuticals, Inc. (DAWN)
VASCONCELLES MICHAEL — Head of Research and Dev.
Shares
2,728
Price
$11.60
Total Value
$31.65K
Shares Held After
4,397
% of Holdings
38.3%
Day One Biopharmaceuticals, Inc. (DAWN)
Bender Jeremy — Director
Shares
15,459
Price
$11.60
Total Value
$179.34K
Shares Held After
204,603
% of Holdings
7.0%
Day One Biopharmaceuticals, Inc. (DAWN)
York Charles N II — COO and CFO
Shares
6,065
Price
$11.60
Total Value
$70.36K
Shares Held After
312,025
% of Holdings
1.9%
Day One Biopharmaceuticals, Inc. (DAWN)
Dubow Adam — Gen Counsel & Secretary
Shares
6,395
Price
$11.60
Total Value
$74.19K
Shares Held After
72,694
% of Holdings
8.1%
Day One Biopharmaceuticals, Inc. (DAWN)
Merendino Lauren — Chief Commercial Officer
Shares
5,814
Price
$11.60
Total Value
$67.45K
Shares Held After
60,157
% of Holdings
8.8%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
4,150
Price
$70.01
Total Value
$290.55K
Shares Held After
53,541
% of Holdings
7.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
7,141
Price
$69.21
Total Value
$494.23K
Shares Held After
57,691
% of Holdings
11.0%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
76,857
Price
$1.31
Total Value
$100.54K
Shares Held After
1,520,498
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$480.75
Total Value
$3.79M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$480.75
Total Value
$7.03M
Shares Held After
0
% of Holdings
100.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Hodgson Ian — Chief Operating Officer
Shares
847
Price
$7.38
Total Value
$6.25K
Shares Held After
51,080
% of Holdings
1.6%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$16.08
Total Value
$96.48K
Shares Held After
2,284,379
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$16.08
Total Value
$241.20K
Shares Held After
2,290,379
% of Holdings
0.7%
Gemini Therapeutics, Inc. (GMTX)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
3,231
Price
$62.86
Total Value
$203.10K
Shares Held After
54,324
% of Holdings
5.6%
Gemini Therapeutics, Inc. (GMTX)
Quisel John D — Director
Shares
13,264
Price
$62.86
Total Value
$833.78K
Shares Held After
226,064
% of Holdings
5.5%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
3,256
Price
$62.86
Total Value
$204.67K
Shares Held After
92,589
% of Holdings
3.4%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
2,853
Price
$62.86
Total Value
$179.34K
Shares Held After
52,173
% of Holdings
5.2%
Gemini Therapeutics, Inc. (GMTX)
Stephenson Pamela — Chief Commercial Officer
Shares
5,531
Price
$62.86
Total Value
$347.68K
Shares Held After
80,998
% of Holdings
6.4%
Aura Biosciences, Inc. (AURA)
de los Pinos Elisabet — Director
Shares
47,648
Price
$5.06
Total Value
$241.10K
Shares Held After
409,815
% of Holdings
10.4%
Aura Biosciences, Inc. (AURA)
Hopkins Janet Jill — Chief Medical Officer
Shares
20,401
Price
$5.06
Total Value
$103.23K
Shares Held After
232,284
% of Holdings
8.1%
Aura Biosciences, Inc. (AURA)
Elazzouzi Amy — Senior Vice President, Finance
Shares
8,549
Price
$5.06
Total Value
$43.26K
Shares Held After
75,532
% of Holdings
10.2%
Aura Biosciences, Inc. (AURA)
Plavsic Mark — Chief Technology Officer
Shares
15,890
Price
$5.05
Total Value
$80.24K
Shares Held After
181,397
% of Holdings
8.1%
Aura Biosciences, Inc. (AURA)
Kilroy Conor — Chief Legal Officer and Secretary.
Shares
12,079
Price
$5.05
Total Value
$61.00K
Shares Held After
167,234
% of Holdings
6.7%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,876
Price
$0.64
Total Value
$1.21K
Shares Held After
218,618
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
220,494
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
222,136
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,032
Price
$0.64
Total Value
$3.24K
Shares Held After
443,404
% of Holdings
1.1%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,979
Price
$0.64
Total Value
$2.56K
Shares Held After
448,436
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,851
Price
$0.64
Total Value
$3.76K
Shares Held After
452,415
% of Holdings
1.3%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
2,022
Price
$0.64
Total Value
$1.30K
Shares Held After
119,752
% of Holdings
1.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
836
Price
$0.64
Total Value
$537.88
Shares Held After
121,774
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
611
Price
$0.64
Total Value
$393.12
Shares Held After
122,610
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
2,041
Price
$331.96
Total Value
$677.53K
Shares Held After
21,264
% of Holdings
8.8%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$27.59
Total Value
$11.51K
Shares Held After
44,089
% of Holdings
0.9%
Avista Public Acquisition Corp. II (AHPA)
Berkman Charles S — Chief Legal Officer
Shares
6,990
Price
$1.70
Total Value
$11.88K
Shares Held After
383,623
% of Holdings
1.8%
Avista Public Acquisition Corp. II (AHPA)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
6,828
Price
$1.70
Total Value
$11.61K
Shares Held After
259,402
% of Holdings
2.6%
Avista Public Acquisition Corp. II (AHPA)
FOEHR MATTHEW W — Director
Shares
20,754
Price
$1.70
Total Value
$35.28K
Shares Held After
4,375,787
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
936
Price
$32.78
Total Value
$30.69K
Shares Held After
34,018
% of Holdings
2.7%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
6,064
Price
$32.30
Total Value
$195.87K
Shares Held After
34,954
% of Holdings
14.8%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$474.68
Total Value
$23.73K
Shares Held After
220
% of Holdings
18.5%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
89
Price
$8.47
Total Value
$753.83
Shares Held After
7,677
% of Holdings
1.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President
Shares
78
Price
$8.47
Total Value
$660.66
Shares Held After
7,789
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Young Teresa L. — EVP, Chief Commercial & Strategy Officer
Shares
75
Price
$8.47
Total Value
$635.25
Shares Held After
8,557
% of Holdings
0.9%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$8.47
Total Value
$2.19K
Shares Held After
11,577
% of Holdings
2.2%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
21,162
Price
$43.90
Total Value
$929.01K
Shares Held After
21,120
% of Holdings
50.0%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
9,088
Price
$43.61
Total Value
$396.33K
Shares Held After
42,282
% of Holdings
17.7%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
3,856
Price
$43.79
Total Value
$168.85K
Shares Held After
17,524
% of Holdings
18.0%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,278
Price
$43.00
Total Value
$1.47M
Shares Held After
1,042,579
% of Holdings
3.2%
Showing 1751–1800 of 3515 transactions (page 36 of 71)